MedicaidPrior AuthMedium impact
Vectibix (panitumumab) (New)
Humana·OH · Oncology, Hematology·Medicaid
Effective date
Feb 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicaid Ohio has established a new prior authorization policy for Vectibix (panitumumab) effective February 1, 2026, covering treatment for metastatic colorectal cancer patients with specific genetic markers. The policy requires prior authorization for all Vectibix treatments and includes strict criteria based on RAS mutation status and prior treatment history.
Action Required
Before February 1, 2026: Billing team must implement prior authorization requirements for all Vectibix (panitumumab) claims for Humana Medicaid Ohio patients. Update billing system to flag these cases and ensure providers document RAS mutation status, cancer staging, and prior treatment history before administration. Claims submitted without proper prior authorization will be denied.